Efficacy of smartphone application based rehabilitations in patients with chronic respiratory or cardiovascular disease

Asan Medical Center0 个研究点目标入组 182 人开始时间: 待定最近更新: 2023年4月4日

试验速览

暂无简介。

•Obstructive pulmonary disease, bronchiectasis, restrictive pulmonary disease
•- Chronic respiratory disease (obstructive pulmonary disease,
•- Bronchiectasis,
•- Restrictive pulmonary disease with dyspnea of mMRC 1 or higher is intended for patients.
•- Coronary artery disease, angina pectoris, myocardial infarction, heart failure,
•* Chronic respiratory disease is based on the following criteria.
•* Obstructive pulmonary disease (chronic obstructive pulmonary disease, asthma, etc.): FEV1/FVC < 0.7 or FEV1 < 80% of the normal predicted value
•* Bronchiectasis: bronchiectasis confirmed in one or more lung lobes on chest CT
•* Restrictive lung disease (interstitial lung disease, etc.): FVC or DLCO < 80% of the normal predicted value
•* The subjects of cardiac rehabilitation are patients with coronary artery disease
•(angina pectoris, myocardial infarction) and heart failure with NYHA 2 or higher dyspnea.
•* Coronary artery disease: Patients who underwent reperfusion or surgery for angina pectoris or myocardial infarction
•* Heart failure: Patients being treated for left ventricular insufficiency (LVEF < 50%)

•- Patients who have been hospitalized due to worsening of the disease within the last 4 weeks
•- Patients unable to perform the rehabilitation program provided by the app
•- Patients who are not suitable for participation in the study according to the judgment of the researcher
•- Patients who refused to consent to the study

发起方